Movement Disorders Clinical Practice

Article	Citations
Issue Information	89
	75
	50
ERRATUM	47
Issue Information	44
FulminantSSPEPresenting as a Hyperkinetic Movement Disorder	41
Spasmodic Dysphonia in a Patient with Spinocerebellar Ataxia Associated with a Rare AFG3L2 Variant (ATX‐AFG3L2)	40
Juvenile Gerstmann‐Sträussler‐Scheinker Disease Mimicking Anticipation Phenomenon	36
Spastic Paraplegia Type 30 Associated with Levodopa‐Responsive Parkinsonism	36
Differential Findings on Anorectal Manometry in Patients with Parkinson's Disease and Defecatory Dysfunction	36
Movement Disorder Society Unified Parkinson's Disease Rating Scale Motor Examination Retains Its 2‐Domain Profile in Both On and Off States	32
Hypomagnesemia: A Rare Cause of Movement Disorders, Myopathy and Vertical Nystagmus	28
Expanding MAPT p.V363I Mutation Phenotype: An Overlapping of PSP‐CBS and Posterior Cortical Atrophy	28
Ears of the Lynx on Neuroimaging in a Patient with COQ4‐Associated Hereditary Spastic Paraplegia	27
Classification and Diagnosis of Cervical Dystonia: Revived Call for Consensus	27
Atypical Presentations of Huntington Disease‐like 2 in South African Individuals	25
Misophonia in Tic Disorders and Their Neuropsychiatric Associations	24
Palliative Care of End Stage Parkinsonism: An Overview Including the Five Pillars Framework	24
A Heat Sensitivity Scale for People with Parkinson's Disease	23
Predicting Outcome in a Cohort of Isolated and Combined Dystonia within Probabilistic Brain Mapping	22
Investigating Dopamine Replacement–Associated Fluctuations in Cognition and Mood in Cognitively Unimpaired Parkinson's Disease	22
Polygenic Risk Score Combined with Transcranial Sonography Refines Parkinson's Disease Risk Prediction	22
Complex Multifocal Dystonia, Intellectual Disability, and Stereotypies Due to a Novel DYRK1A Variant	19
Dominant VPS16 Pathogenic Variants: Not Only Isolated Dystonia	18
Deep Brain Stimulation Improves Symptoms in an Individual with Alpha‐Synuclein‐Gene‐Associated Parkinson's Disease	18

Dyskinetic Movement Disorder in Congenital Methemoglobinemia Type II	18
Total Patient Delay: A Comparison of Patient and Clinician/Health System Delays in the Diagnosis of Progressive Supranuclear Palsy and Corticobasal Syndrome	18
Rehabilitation for Functional Dystonia: Cases and Review of the Literature	17
Overcoming Absorption Issues: Success with Inhaled Levodopa in a Gastrectomized PD Patient	17
Exploring the Pathogenicity of SETX I1942T Variant in Ataxia with Oculomotor Apraxia Type 2 Through Segregation Analysis	17
Cognitive and Psychiatric Adverse Effects of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease	16
Abrupt and Severe Onset of Dystonia, Chorea and Hemiplegic Episodes in a Young Boy with a Novel Heterozygous Missense Variant in the GTPase Domain of RHOBTB2	16
Pallidothalamic Tractotomy after Pallidotomy for Medication‐Refractory Dystonia: Preliminary Short‐Term Results from a Case Series of Five Patients	16
Intermittent Apomorphine Use for off Period Rescue in Parkinson's Disease: A Pragmatic Review of over Three Decades of Clinical Experience	16
Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia	15
Improvement of Motor Function in SLC39A8‐Related Ataxia Through Manganese Supplementation: A Therapeutic Insight	15
Correction to “The Prevalence of Parkinson Disease in Ukraine”	15
Antiphospholipid‐Related Chorea: Two Case Reports and Role of Metabolic Imaging	15
Issue Information	15
Presence Hallucinations during Locomotion in Patients with Parkinson's Disease	15
Patient Experience and Feasibility of a Remote Monitoring System in Parkinson's Disease	15
Comparison of Monopolar Review to Fixed Parameter Fractionation in Deep Brain Stimulation	15
Striatal Dopaminergic Function and Motor Slowing in Essential Tremor Plus	15
Oculogyric Crisis in a Wilson's Disease Patient	15
Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel	14
Factors Influencing Triage to Rehabilitation in Functional Movement Disorder	14
Argyrophilic Grain Disease Clinically Presenting as Progressive Supranuclear Palsy with Progressive Gait Freezing	14
Enhancing the Evaluation of Opicapone in Early Wearing‐Off Symptoms of Parkinson's Disease: A Critical Review and Recommendations for Future Research	14
	13
Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease	13
Healthcare Differences and COVID‐19 Impact on Parkinson's Disease	13
Spectrum and Evolution of Movement Disorder Phenomenology in a Pediatric Powassan Encephalitis Case Series	13
Oral Levodopa Therapy, Vitamin B6 and Peripheral Neuropathy: A Cross‐Sectional Observational Study	13
Premonitory Urge and Tic Severity, Comorbidities, and Quality of Life in Chronic Tic Disorders	13
Reply to Comment on “Patients’ Postjudice of Tele‐Neurology for Movement Disorders”	13
Botulinum Toxin Efficacy in Upper Limb Tremor: A Systematic Review and Meta‐Analysis	13
Neurodevelopmental Disorder and Late‐Onset Degenerative Parkinsonism in a Patient with a WDR45 Defect	13
Tics and Tic‐Like Phenomena as Compulsive Acts	13
The Gray Area of Freezing of Gait Annotation: A Guideline and Open‐Source Practical Tool	13
Pyridoxine‐Dependent Epilepsy: A Treatable Epilepsy Syndrome Presenting with Dystonia and Congenital Cataracts with a Novel Mutation	12
Dystonia Improvement with African Dance	12
Clinical Evaluation of N‐Acetyl‐l‐Leucine in Niemann–Pick Disease Type C: A Critical Perspective	12
The Relationship between PDQ‐8 and Costs in Parkinson's Disease—A Swedish Register‐Based Study	12
Challenges in Establishing the Diagnosis of PRRT2‐Related Dystonia: Recurrent Pathogenic Variants in a Homopolymeric Stretch	12
From the Dance Floor to the Brain: The Effects of Music and Dance on Movement Disorders	12
Slow Periodic Spasms and Rapidly Progressive Parkinsonism Due to Cerebral Amyloid Angiopathy	12
Reply: Pattern Specific Dysgraphia—Beyond Letter Specificity	12
Efficacy of Hypnosis and Catalepsy Induction in Functional Neurological Disorders	12
The Myriad Presentations of Tetanus: Where Do You Look for Clinical Clues in an Intubated Highly Sedated Patient?	11
Randomized Observer‐Blind Study on the Effects of Neuromuscolar Taping in Parkinson's Disease Patients	11
Rapid Progression and Shorter Survival in Indians Affected with Probable MSA: A Prospective Cohort Study	11
Huntington Study Group's Neuropsychology Working Group: Implementing Non‐Motor Diagnostic Criteria	11
Post‐Traumatic Jerky Scapula and Neck: Neurophysiological Evidence of Functional Etiology	11
Deep Brain Stimulation in Classical Galactosemia: A Case‐Report	11
Two Cases of TMEM151A‐Associated Paroxysmal Dyskinesia in a Single‐Center Series of PRRT2‐Negative Patients	11

How Vacations Affect Parkinson's Disease	11
The Effect of Exercise on Nonmotor Symptoms in Parkinson's Disease with Deep Brain Stimulation	11
Posterior Subthalamic Area Deep Brain Stimulation Combined with Spinal Cord Stimulation in a Patient with Spinocerebellar Ataxia Type 12	11
Predictors of Loneliness in Parkinson's Disease and Craniocervical Dystonia	11
Benign Hereditary Chorea as a Manifestation of HPCA Mutation	11
Oculomasticatory Myorhythmia, an Underrecognized Yet Key Finding for the Topographic and Etiological Diagnosis in Patients with Rhombencephalitis. Videographic Record of a Case	11
Paroxysmal Tonic Upward Gaze: A Clinical Clue for CACNA1A‐Related Disorders	10
The Dentate Nucleus Is the Clue: Erdheim–Chester Disease as a Cause of Cerebellar Syndrome	10
	10
Disorder of the Neuromuscular Junction as a Mimic of Focal Dystonia	10
Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification Trials	10
	10
Generalized Dystonia Due to KMT2B Mutation in a Patient with a Previous Diagnosis of Russell Silver Syndrome	10
Foot‐Tapping fMRI‐Guided rTMS Enhances Motor and Cognitive Functions in Parkinson's Disease: A Three‐Year Follow‐Up	10
Compressive Cervical Myelopathy Causing Impaired Gait after Deep Brain Stimulation Is Not Rare	10
Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa	10
A Case of Isoniazid‐Induced Cerebellar Syndrome	10
KCNMA1‐Related Episodes of Behavioral Arrest and Loss of Postural Reflexes: A Critical Reappraisal	9
Report of A Family with Adult‐Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Without Mutations in CSF1R, AARS1 or <	9
Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far	9
Deep Brain Stimulation for a Patient with Familial Parkinson's Disease Harboring CHCHD2 p.T61I	9
Defining “Dystonic Tremor”	9
Rescue Pallidotomy for Chorea Paralytica	9
Tics and Tic‐like Phenomena—Old Questions on a Grand New Scale Invited Editorial on TikTok and Tics	9
Delayed Normal Pressure Hydrocephalus after Deep Brain Stimulation in Parkinson's Disease	9
Continuous Monitoring of Essential Tremor: Standards and Challenges	9
Three‐Week Video‐ and Home‐Based Training Program for People with Ataxia: A Pilot Randomized Controlled Trial	9
Prevalence of Myofascial Trigger Points in Isolated Idiopathic Cervical Dystonia: A Possible Contributor to Pain, Movement and Disability	9
Entrainment Characteristics of Functional Tremor	9
Life‐Space Mobility and Parkinson's Disease. A Multiple‐Methods Study	9
Symptom Network Analysis in a Large Sample of Children and Adults with a Chronic Tic Disorder	9
Adult‐Onset BPAN: An Atypical Presentation Mimicking Early‐Onset Parkinson's Disease	9
Development of a New Care Pathway for Depression and Anxiety in Adult‐Onset Isolated Dystonia	9
Sink or Swim: Using Remote Programming to Manage a Very Australian Problem	9
	8
VPS13C‐Related Parkinson's Disease: Report of a Novel Variant from India and Systematic Review of the Literature	8
Elimination of STN stimulation‐induced dyskinesias with VIM‐DBS	8
Issue Information	8
Genetic Testing for Parkinson's Disease and Movement Disorders in Less Privileged Areas: Barriers and Opportunities	8
Family with BCL11B Related Dystonia and Movement Disorders	8
Various Gait Patterns in Chorea‐Acanthocytosis	8
Adapting STN‐DBS Stimulation Pattern for the Treatment of “Choreo Dystonic Lower Limb Dyskinesia” in Parkinson's Disease	8
Pediatric Onset of Generalized Dystonia, Cognitive Impairment, and Dysmorphic Features in a Patient Carrying Compound Heterozygous GNAL Mutations	8
	8
FBXO7 Pathogenic Variants in Early‐Onset Parkinsonism: Insights from a Neuroimaging Perspective and Review of the Literature	8
Chorea‐Acanthocytosis Presenting with Parkinsonism‐Dystonia without Chorea	8
Cognitive Changes in Pre‐ataxic Spinocerebellar Ataxias: A Scoping Review	8
Meropenem‐Induced Facial Myoclonus	8
Parkinsonism Secondary to Cobra Bite: A Rare and Toxic Complication Due to Basal Ganglia Injury	8
Patients with Cognitive Impairment in Parkinson's Disease Benefit from Deep Brain Stimulation: A Case‐Control Study	8
Anthropology of Deep Brain Stimulation; the 30th Anniversary of STN DBS in 2023	8
Novel RAB39B Mutation Causes Parkinsonism in Males with Developmental Disorder	8
Post–COVID‐19 Myoclonus–Ataxia Syndrome Responsive to Intravenous Immunoglobulins	8
Development and Validation of a Prognostic Model to Predict Overall Survival in Multiple System Atrophy	8
Exploring the Impact of Dyskinetic Crises in GNAO1‐Related Disorders: A Survey for Parents and Caregivers	7
Identifying the Diagnostic Challenges and Indicators of Orthostatic Tremor: Patient Perspectives	7
Autoimmunity Panels: Needs and Implementation in the Underdeveloped Regions and how to Approach the Disparities	7
Brain Oedema Associated with Deep Brain Stimulation through a Single Directional Contact	7
Chromosome Microarray Analysis for the Investigation of Deletions in Pediatric Movement Disorders: A Systematic Review of the Literature	7
Amantadine‐Induced Craniofacial Myoclonus: Distinctive Iatrogenic Dysarthria in Parkinson's Disease	7
Analysis of DBS Outcome by MDS‐UPDRS Severity Levels: Comparison with Changes on MDS‐UPDRS III	7
Editor's Note	7
De Novo Missense Mutation of VPS16 in a Chinese Patient with Generalized Dystonia with Myoclonus	7
Immune Checkpoint Inhibitor‐Associated Striatal Encephalitis Presenting with Subacute Progressive Parkinsonism	7
Deep Brain Stimulation Withdrawal without Relapse in Chorea‐Acanthocytosis: Two Case Reports	7
Illustration of the Long‐Term Efficacy of Deep Brain Stimulation of the Thalamic Ventral Intermediate Nucleus in a Patient with Holmes Tremor Secondary to Stroke	7
Levodopa Equivalent Daily Dosage: Geographical Variations and Real‐Life Modules in Parkinson's Disease	7
Risk of Neurodegenerative Disease after Viral Infections: The Increasing Load of Evidence	7
Reply to Letter: “MTFMT‐Related Leigh Syndrome Phenotypically Manifesting with Mobile Dystonia and Hypoacusis”	7
Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease	7
Stimulation‐Induced Dyskinesia in STN DBS Patients	7
Striatal Hand Deformities in Parkinson's Disease: Hand Surgical Perspectives	7
Effects of Different Exercise Programs on Symptoms, Sleep, and Quality of Life in Patients with Primary Restless Legs Syndrome	7
Dystonic Tremor as the Clinical Manifestation of Fragile X‐Associated Tremor/Ataxia Syndrome	7
Phenotypic Variability in Acquired and Idiopathic Dystonia	7
“Relapsing–Remitting” Ataxia and Unexpected Brain Imaging in a Child with HIBCH Deficiency	7
Skin Conditions and Movement Disorders: Hiding in Plain Sight	7
Issue Information	7
Safety and Efficacy of Long‐Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open‐Label Extension Study	7
Social Cognition in Parkinson's Disease: A Case‐Control Study	6

Improvement of ADCY5‐Related Dyskinesias with Coffee	6
	6
Very Late‐Onset Neurodegeneration with Brain Iron Accumulation Associated with Mild Chorea: A Clinicopathological Case	6
Disability Milestones and Death in Parkinson's Disease under Subthalamic Neurostimulation	6
Telehealth Transdiagnostic Cognitive Behavioral Therapy for Depression in Parkinson's Disease: A Pilot Randomized Controlled Trial	6
MTFMT‐Related Leigh Syndrome Phenotypically Manifesting with Mobile Dystonia and Hypoacusis	6
Facio‐Lingual‐Palatal Myorhythmic Presentation of Anti‐IgLON5 Disease	6
Blepharospasm in GNAO1 Syndrome May Benefit From Botulinum Toxins	6
Editors Note: Looking Forward, Looking Back	6
Issue Information	6
Author Index	6
The Impact of Deep Brain Stimulation of the Subthalamic Nucleus on Sleep–Wake Function and Circadian Rhythms in Patients with Parkinson's Disease	6
Expanding the Clinical Spectrum of Head Snap Sign	6
	6
Amantadine Treatment for Hyperkinetic Movements in Chorea‐Acanthocytosis	6
X‐Linked Levodopa‐Responsive Parkinsonism‐Epilepsy Syndrome: A Novel PGK1 Mutation and Literature Review	6
Mild Neurological Phenotype Associated with Hypomorphic Variants in the Ataxia‐Telangiectasia Mutated Gene	6
Successful Treatment of Baseball‐Related Dystonia (Yips) with Ventro‐Oral Thalamotomy	6
Outcomes of Percutaneous Endoscopic Gastrostomy in Huntington's Disease at a Tertiary Center	6
What Is Hemidystonia?	6
Lower Facial Dystonia: An Unexpected Presentation Associated with Pathogenic RFC1 Repeat Expansions	6
	6
Correction to “Gerstmann‐Sträussler‐Scheinker Disease Presenting as Late‐Onset Slowly Progressive Spinocerebellar Ataxia, and Comparative Case Series with Neuropathology”	6
Sporadic Fatal Insomnia Presenting with Initial Symptoms of Parkinsonism and Abnormal Dopamine Transporter Imaging	6
Clinical and Biomechanical Factors in the Sit‐to‐Stand Decline in Parkinson's Disease	6
Adult‐Onset Cerebellar Ataxia as Clinical Manifestation of Eukaryotic Initiation Factor 2B4 Point Mutation	6
Comparing Essential Tremor with and without Soft Dystonic Signs and Tremor Combined with Dystonia: The TITAN Study	6
	6
Huntington's Disease Gene Hunters: An Expanding Tale	6
ADCY5 Related Dyskinesia—A Rare Mutation	6
Pharmacological Interventions for Sialorrhoea in People with Parkinson's Disease: A Systematic Review and Meta‐Analysis	6
Relevance of Antibody Testing in Movement Disorders	6
Impact of Parkinson's Disease on Caregiver Quality of Life in Japan	6
How to Transition from a Movement Disorder Fellowship to an Academic Position	6
Prosaccade and Antisaccade Behavior in Fragile X‐Associated Tremor/Ataxia Syndrome Progression	6
A Rare Case of Ophthalmoplegia with Ataxia in Genetically Proven Abetalipoproteinemia	6
Childhood‐Onset Choreo‐Dystonia Due to a Recurrent Novel Homozygous Nonsense HPCA Variant: Case Series and Literature Review	6
Adult‐Onset Dystonia‐Parkinsonism: Do Not Forget SERAC1	6
Device‐Aided Treatment of Parkinsonism in Cerebrotendinous Xanthomatosis	6
Issue Information	5
Correlation of Antidepressant Use and Symptom Time Period in Dream Enactment Behaviors	5
Syndrome of Tremor, Ataxia, Hearing Loss, and Seizure in a Young Adult: Think Neurobrucellosis	5
Huntington's Disease‐Like 2 in a European Caucasian Patient	5
Tremor Is Highly Responsive to Levodopa in Advanced Parkinson's Disease	5
Mimics or Multiplicity: 2 Cases of Rare Neurological Conditions Discovered Following Presentation with Richardson's Syndrome Phenotype	5
A Phase Ib, Double Blind, Randomized Study of Cannabis Oil for Pain in Parkinson's Disease	5
Spinocerebellar Ataxia Type 6 and Japanese Immigration to Brazil	5
Sex Differences in Neuropsychiatric Symptoms in Alpha‐Synucleinopathies: A Systematic Review and Meta‐Analysis	5
A Woman with Progressive Ataxia and Abnormal Eye Movements	5
Vitamin C Deficiency Presenting with Progressive Gait Difficulty, Myopathy, and Movement Disorder in a Toddler	5
Issue Information	5
Tremor/Myoclonus Syndrome Associated with Thrombotic Thrombocytopenic Purpura: Case Report and Review of Literature	5
Visuospatial Deficits Are Associated with Pisa Syndrome and not Camptocormia in Parkinson's Disease	5
The Vodka Trial: Clinical and Genetic Characteristics of Alcohol Responsiveness in Laryngeal Dystonia	5
Opsoclonus‐Myoclonus: Not Always Paraneoplastic	5
Case Report of Bilateral Subthalamic Nucleus Deep Brain Stimulation in an Adolescent TUBB4A Patient: She Can Sit on a Horse	5
A Case of Chorea with Slow Saccades Caused by NKX2‐1 Mutation	5
Prevalence and Clinical Characteristics of the LRRK2 p.L1795F Variant in Central Europeans with Early‐Onset and Familial Parkinson's Disease	5
Oral Squamous Cell Carcinoma Presenting as a Stiff Tongue	5
Issue Information	5
Safety and Effect of 12‐Month Ecopipam Treatment in Pediatric Patients with Tourette Syndrome	5
Pseudoathetosis: An Unusual Initial Presentation of Compressive Cervical Myelopathy	5
The Importance of Standardized Assessment	5
Acanthamoeba Encephalitis Presenting as Rapidly Developing Parkinsonism—A Wolf in Sheep's Clothing	5
Dystonia as Presenting Feature of Compound Heterozygous PMPCA Gene Variants	5
The Persistence of Dopamine Dysregulation Syndrome after Pallidal Deep Brain Stimulation in Parkinson's Disease	5
Co‐Occurrence of Apathy and Impulsivity in Progressive Supranuclear Palsy	5
Pharmacological Treatment of Neuropsychiatric Symptoms in Huntington's Disease: A Systematic Review	5
Therapeutic Benefit of Sensory Trick in Cervical Dystonia	5
Head Drop and Trunk Flexion as an Early Manifestation of Anti‐IgLON5 Disease	5
STUB1‐Associated Autosomal‐Recessive Spinocerebellar Ataxia Type 16 (SCAR16) Presenting with Gordon–Holmes Syndrome Caused by Maternal Uniparental Isodisomy	5
Elevated Cerebrospinal Fluid α‐Synuclein Seeding Activity Predicts Central Lewy Body Diseases	5
Erratum	5
Spastic Paraplegia and Cognitive Impairment Due to a De Novo Pathogenic Variant inPresenilin‐1	5
Treat by Suggestion: The Potential Use of N = 1 Trials in Functional Neurological Disorders	4
Randomized Controlled Trial of Transcranial Direct Current Stimulation over the Supplementary Motor Area in Tourette Syndrome	4
From Hopelessness to Hope: Addressing Demoralization in Parkinson's Disease	4
How Do I Examine Laryngeal Dystonia?	4
	4
Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population‐based Study	4
Co‐Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications	4
Early Onset Dystonia, Parkinsonism, and Spasticity in Siblings with VAC14‐Associated Neurodegeneration: A Case Report and Literature Review	4
The Optimal Targeting for Focused Ultrasound Thalamotomy Differs between Dystonic and Essential Tremor: A 12‐Month Prospective Pilot Study	4
Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease	4
Pulse‐Generator Rejection of Probable Allergic Origin in Deep Brain Stimulation: A Rare Complication Successfully Managed with a Polytetrafluoroethylene‐Covered Device	4
Benefits and Risks of a Staged‐Bilateral VIM Versus Unilateral VIM DBS for Essential Tremor	4
Phenotyping Gaze: Hallmarks of Recessive Ataxia with PNKP Gene Variant	4
Touchscreen Smartphone Interaction in Parkinson's Disease and Healthy Subjects in Outpatient Clinics	4
Clinical Practices and Opinions toward Gastrostomy Use in Patients with Atypical Parkinsonian Syndromes: A National Survey in the UK	4
Validation of the French Translation of the Movement Disorder Society Non‐Motor Symptoms Scale (MDS‐NMS) in Parkinson's Disease	4
Subcutaneous Foslevodopa as Novel Rescue Therapy for Akinetic Crisis in Parkinson's Disease: A Case Report	4
Cranial Myorhythmia as a Novel Clinical Manifestation in Contactin‐Associated Protein‐like 2 (CASPR2) Antibody Associated Encephalitis	4
Neuro‐Ophthalmological Manifestations of Episodic Ataxia Type 2 Due to a Novel CACNA1A Mutation	4
The Quality in Quality of Life in Parkinson's Disease: A Qualitative Meta‐Synthesis	4
Status of Current Biofluid Biomarkers in Parkinson's Disease	4